| OR* | 95% CI | p-value | N |
---|---|---|---|---|
COX-2 and pAkt Ser473 | ||||
All patients | 1.52 | 1.05-2.09 | 0.024 | 211 |
ERNEG | 1.47 | 0.84-2.57 | 0.181 | 89 |
ERPOS | 1.57 | 0.96-2.57 | 0.072 | 121 |
HER2NEG | 1.33 | 0.87-2.02 | 0.183 | 135 |
HER2POS | 2.99 | 1.09-8.15 | 0.034 | 76 |
ERNEG/HER2POS | 4.87 | 0.90-26.2 | 0.065 | 25 |
COX-2 and pAkt Thr308 | ||||
All patients | 1.99 | 1.31-3.02 | 0.001 | 207 |
ERNEG | 1.85 | 0.98-3.50 | 0.057 | 87 |
ERPOS | 2.08 | 1.18-3.63 | 0.011 | 119 |
HER2NEG | 1.76 | 1.09-2.86 | 0.021 | 134 |
HER2POS | 4.25 | 1.44-12.6 | 0.009 | 72 |
ERNEG/HER2POS | 14.9 | 1.43-154 | 0.024 | 23 |
COX-2 and pCasp9 Ser196 | ||||
All patients | 1.90 | 1.36-2.65 | 0.000 | 211 |
ERNEG | 1.84 | 1.06-3.22 | 0.030 | 89 |
ERPOS | 2.01 | 1.31-3.08 | 0.001 | 121 |
HER2NEG | 1.56 | 1.06-2.29 | 0.025 | 135 |
HER2POS | 3.35 | 1.41-7.91 | 0.006 | 76 |
ERNEG/HER2POS | 16.3 | 1.72-154.6 | 0.015 | 25 |
COX-2 and pBAD Ser136 | ||||
All patients | 1.61 | 1.20-2.16 | 0.001 | 209 |
ERNEG | 1.58 | 1.04-2.38 | 0.032 | 89 |
ERPOS | 1.66 | 1.09-2.54 | 0.019 | 119 |
HER2NEG | 1.42 | 0.99-2.02 | 0.051 | 135 |
HER2POS | 2.21 | 1.22-3.95 | 0.008 | 74 |
ERNEG/HER2POS | 4.10 | 1.15-14.7 | 0.030 | 25 |